Hippo 通路共激活因子 Yap 和 Taz 对于协调哺乳动物肝脏再生是必需的。

Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration.

机构信息

Department of Genetics, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

Baylor Genetics, Baylor College of Medicine, Houston, TX, USA.

出版信息

Exp Mol Med. 2018 Jan 5;50(1):e423. doi: 10.1038/emm.2017.205.

Abstract

The mammalian liver has a remarkable capacity for repair following injury. Removal of up to two-third of liver mass results in a series of events that include extracellular matrix remodeling, coordinated hepatic cell cycle re-entry, restoration of liver mass and tissue remodeling to return the damaged liver to its normal state. Although there has been considerable advancement of our knowledge concerning the regenerative capacity of the mammalian liver, many outstanding questions remaining, such as: how does the regenerating liver stop proliferating when appropriate mass is restored and how do these mechanisms relate to normal regulation of organ size during development? Hippo pathway has been proposed to be central in mediating both events: organ size control during development and following regeneration. In this report, we examined the role of Yap and Taz, key components of the Hippo pathway in liver organ size regulation, both in the context of development and homeostasis. Our studies reveal that contrary to the current paradigms that Yap/Taz are not required for developmental regulation of liver size but are required for proper liver regeneration. In livers depleted of Yap and Taz, liver mass is elevated in neonates and adults. However, Yap/Taz-depleted livers exhibit profound defects in liver regeneration, including an inability to restore liver mass and to properly coordinate cell cycle entry. Taken together, our results highlight requirements for the Hippo pathway during liver regeneration and indicate that there are additional pathways that cooperate with Hippo signaling to control liver size during development and in the adult.

摘要

哺乳动物的肝脏在受伤后具有出色的修复能力。即使切除多达三分之二的肝脏组织,也会引发一系列事件,包括细胞外基质重塑、协调的肝细胞周期重新进入、肝质量的恢复以及组织重塑,使受损的肝脏恢复到正常状态。尽管我们对哺乳动物肝脏的再生能力有了相当大的了解,但仍有许多悬而未决的问题,例如:当适当的质量恢复时,再生的肝脏如何停止增殖,以及这些机制如何与发育过程中正常的器官大小调节相关?Hippo 通路被认为是介导这两个事件的核心:发育过程中和再生后器官大小的控制。在本报告中,我们研究了 Yap 和 Taz(Hippo 通路的关键组成部分)在肝脏器官大小调节中的作用,包括在发育和稳态方面的作用。我们的研究表明,与目前的范式相反,Yap/Taz 不是发育性调节肝脏大小所必需的,但对于适当的肝脏再生是必需的。在 Yap 和 Taz 耗竭的肝脏中,新生儿和成年肝脏的质量增加。然而,Yap/Taz 耗竭的肝脏在肝脏再生中表现出严重的缺陷,包括无法恢复肝质量和正确协调细胞周期进入。总之,我们的结果强调了 Hippo 通路在肝脏再生中的重要性,并表明在发育过程中和成年肝脏中存在与 Hippo 信号协同作用以控制肝脏大小的其他途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f18a/5992983/24aaf08b8f1e/emm2017205f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索